{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:19:11Z","timestamp":1720221551943},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.vaccine.2012.05.001","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T06:04:23Z","timestamp":1346393063000},"page":"C38-C44","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S3","title":["Combination vaccines in the South African setting"],"prefix":"10.1016","volume":"30","author":[{"given":"Adele","family":"Visser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwar","family":"Hoosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.05.001_bib0005","unstructured":"Global Alliance for Vaccines and Immunization. <http:\/\/www.gavialliance.org\/about\/mission\/impact\/> [accessed 20.10.11]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0010","unstructured":"UNICEF. <http:\/\/www.childinfo.org\/hiv_aids.html> [accessed 28.12.11]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pedhc.2007.09.004","article-title":"Societal impact of combination vaccines: experiences of physicians, nurses, and parents","volume":"22","author":"Koslap-Petraco","year":"2008","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0020","series-title":"Epidemiology and prevention of vaccine-preventable diseases","first-page":"1","article-title":"Pertussis","year":"2006"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0025","first-page":"1","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006454-199405000-00005","article-title":"Safety and immunogenicity in young infants of Haemophilus b\u2013tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria\u2013tetanus-enhanced inactivated poliovirus vaccine","volume":"13","author":"Dagan","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/mpd.2000.109026","article-title":"Combination vaccines: problems and promise","volume":"137","author":"Decker","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0040","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00006454-199707000-00010","article-title":"Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in 2-, 4-, and 6-month-old infant with combination Haemophilus influenzae type b\/hepatitis B vaccine","volume":"16","author":"Halsey","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0045","first-page":"314","article-title":"Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers","volume":"9","author":"Marcy","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0050","series-title":"Vaccines","first-page":"1069","article-title":"Combination vaccines","author":"Decker","year":"2008"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0055","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/00006454-200111001-00007","article-title":"Safety of combination vaccines: perception versus reality","volume":"20","author":"Halsey","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0060","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archpedi.1995.02170210019003","article-title":"Physician and parent opinions: are children becoming pincushions from immunizations?","volume":"149","author":"Woodkin","year":"1995","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/biol.1994.1054","article-title":"Control testing of combined vaccines: a considerations of potential problems and approaches","volume":"22","author":"Corbel","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0070","series-title":"Combined vaccines and simultaneous administration: current issues and perspectives","first-page":"10","article-title":"FDA perspective on regulatory issues in vaccine development","author":"Anthony","year":"1995"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0075","series-title":"Combined vaccines and simultaneous administration: current issues and perspectives","first-page":"35","article-title":"Potential alterations in immunogenicity by combining or simultaneous administering vaccine components","author":"Insel","year":"1995"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1542\/peds.106.5.1097","article-title":"Do parents understand immunizations? A national telephone survey","volume":"106","author":"Gellin","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/000992280404300112","article-title":"Clinicians satisfaction with vaccination visits and the role of multiple injections, results from the COVISE study (Combination Vaccines Impact on Satisfaction and Epidemiology)","volume":"43","author":"Meyerhoff","year":"2004","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ypmed.2004.12.001","article-title":"Do too many shots due lead to missed vaccination opportunities? Does it matter?","volume":"41","author":"Meyerhoff","year":"2005","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0095","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.vaccine.2006.02.049","article-title":"Timeliness of childhood immunisation in Australia","volume":"24","author":"Hull","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0100","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1542\/peds.2006-0114","article-title":"Use of a new combined vaccine in pediatric practices","volume":"118","author":"Freed","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines had improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0110","first-page":"3","article-title":"Improving quality by encouraging providers to use pediatric combination vaccines","volume":"6","author":"Goldfarb","year":"2005","journal-title":"Manag Care"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0115","series-title":"World development report 1993","year":"1993"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0120","series-title":"State of the world's vaccines and immunization","year":"2012"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0125","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/S0264-410X(00)00073-6","article-title":"The introduction of new vaccines into developing countries II. Vaccine financing","volume":"18","author":"Mahoney","year":"2000","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.05.001_bib0495","doi-asserted-by":"crossref","first-page":"C79","DOI":"10.1016\/j.vaccine.2012.04.042","article-title":"Financing vaccinations\u2014the South African experience","volume":"30","author":"Blecher","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0135","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1016\/j.vaccine.2008.10.015","article-title":"Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?","volume":"26","author":"Lydon","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0140","unstructured":"Phoshoko S. Vaccine costing in SA, personal communication."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0145","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(00)02325-4","article-title":"Review of regional measles surveillance data in the Americas, 1996\u201399","volume":"355","author":"Hersh","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00006454-199405000-00003","article-title":"Combination vaccines: hopes and challenges","volume":"13","author":"Edwards","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0155","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1086\/322571","article-title":"Considerations for combination vaccine development and use in the developing world","volume":"33","author":"Fabio","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0160","series-title":"Vaccines","first-page":"1542","article-title":"Immunization in developing countries","author":"Hadler","year":"2008"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0165","unstructured":"World Health Organization. Expanded programme on immunization (EPI). <http:\/\/www.who.int\/immunization_delivery\/en\/> [accessed 25.01.12]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0170","first-page":"163","article-title":"Safety of immunization in Africa: not simply a problem of logistics","volume":"78","author":"Dicko","year":"2000","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0175","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.282.18.1763","article-title":"Limiting infant exposure to thimerosal in vaccines and other sources of mercury","volume":"282","author":"Halsey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006454-199709000-00009","article-title":"Vaccine antigen interaction after a combination diphtheria\u2013tetanus\u2013toxoid-acellular pertussis\/purified capsular polysaccharide of Haemophilus infulenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants","volume":"16","author":"Pichichero","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s004310050797","article-title":"Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administred separately or mixed with concomittant diphtheria\u2013tetanus\u2013toxoid and aceullar pertussis vaccine for primary and for booster immunization","volume":"157","author":"Schmitt","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0091-6749(99)70508-7","article-title":"A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids","volume":"103","author":"Nakayama","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJM196601132740203","article-title":"Effects of live type 1 poliovirus vaccine and other viruses on the tuberculin test","volume":"274","author":"Berkovich","year":"1966","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1542\/peds.55.3.392","article-title":"The timing of tuberculin tests in relation to immunization with live viral vaccines","volume":"55","author":"Brickman","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0205","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1086\/322567","volume":"33","author":"Halsey","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0210","series-title":"Adverse events associated with childhood vaccines: evidence bearing on causality","first-page":"59","article-title":"Immunologic reactions","year":"1993"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0215","series-title":"Fundamental immunology","first-page":"479","article-title":"Lymphoid tissues and organs","author":"Pickering","year":"1999"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0220","first-page":"17624","volume":"62","year":"1997","journal-title":"Fed Reg"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0225","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1086\/322566","article-title":"Analysis of studies to evaluate the immune response to combination vaccines","volume":"33","author":"Horne","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0230","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/322578","article-title":"Evaluating the immune response to combination vaccines","volume":"33","author":"Ball","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0235","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00006454-199807000-00016","article-title":"A perspective on combination vaccines","volume":"17","author":"Halsey","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0240","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0022-3476(94)70009-5","article-title":"Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine among Navajo children","volume":"125","author":"Harrison","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0245","unstructured":"US Code of Federal Regulations. Title 21, part 601.25(d)(2). Washington, DC: US Government Printing Office; 2001."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0250","unstructured":"US Code of Federal Regulations. Title 21, part 610.17. Washington, DC: US Government Printing Office; 2001."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0255","unstructured":"US Code of Federal Regulations. Title 21, part 601.25(d)(4). Washington, DC: US Government Printing Office; 2001."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0260","unstructured":"US Code of Federal Regulations. Title 21, part 312.21. Washington, DC: US Government Printing Office; 2001."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","article-title":"Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad)","volume":"2","author":"Kuter","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0270","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00006454-199811000-00003","article-title":"Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-RII, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-RII and TETRAMUNE followed six weeks later by VARIVAX","volume":"17","author":"Shinefield","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0275","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.vaccine.2008.02.041","article-title":"Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV\/Hib vaccine in healthy infants","volume":"26","author":"Schmitt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0280","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/peds.2005-0092","article-title":"A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax","volume":"117","author":"Reisinger","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0290","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1016\/S0264-410X(03)00420-1","volume":"21","author":"Ar\u00edstegui","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0295","first-page":"1","article-title":"Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0300","first-page":"379","article-title":"Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease?","volume":"89","author":"Granoff","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0305","first-page":"S197","article-title":"Lessons for AIDS vaccine development from non-AIDS vaccines","volume":"14","author":"Clements-Mann","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0310","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jama.202.1.111","article-title":"Excessive use of tetanus toxoid boosters","volume":"202","author":"Edsall","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0315","first-page":"280","article-title":"Tetanus-toxoid emergency boosters: a reappraisal","author":"Peebles","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1982.03320260024022","article-title":"Adverse reactions to tetanus toxoid","volume":"247","author":"Jacobs","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1542\/peds.73.1.31","article-title":"DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose","volume":"73","author":"Baraff","year":"1984","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0330","first-page":"99","article-title":"Adverse reactions in adolescents to reinforcing dose of plain and adsorbed tetanus vaccines","volume":"7","author":"Jones","year":"1985","journal-title":"Community Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0335","series-title":"1997 Red Book: report of the Committee on Infectious Diseases","first-page":"518","article-title":"Tetanus (Lockjaw)","year":"1997"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0340","first-page":"1","volume":"40","year":"1991","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence based medicine: what it is and what it isn\u2019t","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0350","series-title":"1997 Red Book: report of the Committee on Infectious Diseases","first-page":"410","article-title":"Pneumococcal infections","year":"1997"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0355","unstructured":"World Health Organization. <http:\/\/www.int\/countries\/en\/> [accessed 25.04.12]."},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.05.001_bib0500","first-page":"C9","article-title":"The decision making process on new vaccine introduction in South Africa","volume":"30","author":"Ntombenhle","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0365","first-page":"879","article-title":"One-year post-primary antibody persistence and booster immune response to a DTaP-IPV\/\/PRP-T vaccine (Pentaxim) given at 18\u201319 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccine","volume":"101","author":"Madhi","year":"2011","journal-title":"S Afr J Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0370","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7196\/SAMJ.4401","article-title":"Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa","volume":"101","author":"Madhi","year":"2011","journal-title":"S Afr J Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0375","first-page":"9","article-title":"The impact of the immunisation programme on vaccine-preventable diseases in South Africa: a review of progress over a 10- to 15-year period","volume":"23","author":"Ngcobo","year":"2008","journal-title":"S Afr J Epidemiol Infect"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.05.001_bib0505","doi-asserted-by":"crossref","first-page":"C35","DOI":"10.1016\/j.vaccine.2012.02.056","article-title":"Introduction of inactivated poio vaccine (IPV) into the routine immunization in South Africa","volume":"30","author":"Schoub","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0385","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1016\/j.vaccine.2006.05.032","article-title":"The cost-effectiveness of alternative polio immunization policies in South Africa","volume":"24","author":"Griffiths","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0390","unstructured":"National Institutes for Communicable Diseases. Polio paralyses child. <http:\/\/www.nicd.ac.za\/?page=alerts&id> [accessed 12.04.12]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0395","unstructured":"National Institute for Communicable Diseases. Annual review 2010\u20132011. <http:\/\/www.nicd.ac.za\/assets.files\/> [accessed 12.04.12]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0400","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2471\/BLT.06.030361","article-title":"Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa","volume":"84","author":"Von Gottberg","year":"2006","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0405","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.vaccine.2011.11.066","article-title":"Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003\u20132009","volume":"30","author":"Von Gottberg","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0410","first-page":"924","article-title":"Laboratory surveillance for Haemophilus influenzae type b, meningococcal and pneumococcal disease. Haemophilus Surveillance Working Group","volume":"89","author":"Huebner","year":"1999","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0415","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02724936.1994.11747700","article-title":"Epidemiology of invasive Haemophilus influenzae infections in Cape Town, South Africa","volume":"14","author":"Hussey","year":"1994","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0420","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2010.11.090","article-title":"Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine","volume":"29","author":"Barnighausen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0425","first-page":"450","article-title":"Introducing pentavalent vaccine in EPI in India: issues involved","volume":"132","author":"John","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0430","first-page":"456","article-title":"Pentavalent & other new combination vaccines: solution in search of problems","volume":"132","author":"Madhavi","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0435","unstructured":"SAVIC. <http:\/\/www.savic.ac.za\/news\/newsarticles.php> [accessed 28.12.11]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0440","first-page":"113","article-title":"Egg allergy and MMR vaccination","volume":"93","author":"Du Toit","year":"2003","journal-title":"S Afr J Med"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.05.001_bib0510","doi-asserted-by":"crossref","first-page":"C58","DOI":"10.1016\/j.vaccine.2012.02.082","article-title":"When should be introduce a combination measles\u2013mumps-(MMR) vaccine into the national childhood expanded immunization programme in South Africa?","volume":"30","author":"Cameron","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0450","first-page":"688","article-title":"Seroprevalence of rubella antibodies among antenatal patients in the Western Cape","volume":"95","author":"Corcoran","year":"2005","journal-title":"S Afr J Med"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0455","first-page":"69","article-title":"Control of rubella and congenital rubella syndrome (CRS) in developing countries. Part 2. Vaccination against rubella","volume":"75","author":"Robertson","year":"1997","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0460","first-page":"164","article-title":"Immunisation coverage estimates by cluster sampling survey of children (aged 12\u201323 months) Gauteng province, 2003","volume":"21","author":"Fonn","year":"2006","journal-title":"S Afr J Epidemiol Inf"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0465","unstructured":"Paediatric Group. <http:\/\/www.paediatrician.co.za> [accessed 21.04.12]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0470","unstructured":"Mail and Guardian. Forty million South African without medical aid. <http:\/\/www.mg.co.za\/article\/2009-07-07-forty-million-south-africans-without-medical-aid> [accessed 21.04.12]."},{"key":"10.1016\/j.vaccine.2012.05.001_bib0475","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.vaccine.2010.02.029","article-title":"The National Advisory Group on Immunization (NAGI) of the Republic of South Africa","volume":"28S","author":"Schoub","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0480","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","article-title":"Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine","volume":"25","author":"Madhi","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0485","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1471-2458-11-404","article-title":"Vaccination coverage and timeliness in three South African areas: a prospective study","volume":"11","author":"Fadnes","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2012.05.001_bib0490","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1016\/j.ijid.2009.11.006","article-title":"Pediatric disease burden and vaccination recommendations: understanding local differences","volume":"14","author":"Gentile","year":"2010","journal-title":"Int J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12006743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:04:49Z","timestamp":1643328289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12006743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":98,"alternative-id":["S0264410X12006743"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}